Welcome to our dedicated page for Primerica SEC filings (Ticker: PRI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking Primerica鈥檚 life-insurance reserves, commission payouts, and the size of its licensed-representative force can be daunting; the company鈥檚 annual report alone spans hundreds of pages packed with actuarial tables and deferred acquisition cost roll-forwards. If you have ever searched for 鈥淧rimerica SEC filings explained simply鈥� or tried to pinpoint the latest 鈥淧rimerica quarterly earnings report 10-Q filing,鈥� you know how quickly EDGAR becomes overwhelming. Digging through 鈥淧rimerica insider trading Form 4 transactions鈥� for clues about executive sentiment only adds to the complexity.
Stock Titan resolves this with AI-powered summaries that translate insurance jargon into clear language, turning 鈥渦nderstanding Primerica SEC documents with AI鈥� from aspiration into reality. Our engine highlights solvency ratios, segment revenue, and policy lapse trends and instantly flags 鈥淧rimerica Form 4 insider transactions real-time,鈥� so you never miss a key share purchase or sale. Even the 鈥淧rimerica annual report 10-K simplified鈥� arrives within moments of EDGAR release, annotated with plain-English explanations of reserve adjustments and capital requirements.
Use our platform to:
- Receive concise 鈥淧rimerica earnings report filing analysis鈥� minutes after each release.
- Monitor 鈥淧rimerica executive stock transactions Form 4鈥� alongside our risk-weighted scoring.
- Dive into 鈥淧rimerica proxy statement executive compensation鈥� tables without scanning 100+ pages.
- Get 鈥淧rimerica 8-K material events explained鈥� so you understand how reinsurance treaties or distributor agreements affect valuation.
Every filing type鈥�10-K, 10-Q, 8-K, DEF 14A, S-8鈥攊s updated in real time and paired with expert commentary. Make informed decisions faster by converting dense disclosures into actionable insights.
Primerica Q2 2025 10-Q highlights
- Revenue inched up 0.3% YoY to $793.3 million; commissions & fees rose 14% while net premiums grew 3.6%.
- Pre-tax income from continuing ops fell 14% to $234.5 million; net income declined to $178.3 million (-15%) as prior-year results contained a one-off $50 million insurance recovery.
- Diluted EPS from continuing ops dropped to $5.40 (-11%); total diluted EPS unchanged by discontinued Senior Health unit, which caused a $208 million loss in Q2 2024.
- Segment performance: Term Life pre-tax profit +5% to $155.0 million; Investment & Savings Products +6% to $79.4 million; Corporate & Other near breakeven versus $50.2 million profit last year.
- Capital returns: 2Q buybacks of $127 million and dividends of $34 million reduced diluted share count 4% YoY to 32.9 million; YTD repurchases total $251 million.
- Balance sheet: Assets $14.83 b (+2% YTD); equity $2.31 b (+2%). Cash fell to $621 million after $329 million financing outflows. AOCI improved by $63 million YTD on discount-rate and FX movements.
- Liquidity & cash flow: Operating cash flow solid at $360 million versus $384 million YTD 2024; investing cash outflow $100 million driven by portfolio reinvestment.
Bottom line: Core franchises showed modest growth, but elevated expenses and loss of 2024鈥檚 non-recurring gain compressed margins. Shareholder payouts remain aggressive, sustaining mid-teens ROE.
FAQ
What is the current stock price of Primerica (PRI)?
What is the market cap of Primerica (PRI)?
